Gadoxetic Acid–enhanced Magnetic Resonance Imaging and Contrast-enhanced Ultrasonography in the Diagnosis of Hepatocellular Carcinoma

Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and one of the leading causes of cancer-related deaths. Early diagnosis of HCC is crucial to achieve good outcome. Advances in imaging technology enable detection of early disease, accurate tumour staging, treatment planning, and posttreatment monitoring, as well as an update of management guidelines. This review focuses on the development of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasonography in the diagnosis of HCC.